Poseida Therapeutics Stock (NASDAQ: PSTX) stock price, news, charts, stock research, profile.
You can purchase shares of Poseida Therapeutics (NASDAQ:PSTX) through any online brokerage.
Other companies in Poseida Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB) and Cogent Biosciences (NASDAQ:COGT).
Poseida Therapeutics has a consensus price target of $14.40.
The stock price for Poseida Therapeutics (NASDAQ: PSTX) is $9.5 last updated December 18, 2024 at 1:27 PM EST.
There are no upcoming dividends for Poseida Therapeutics.
Poseida Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for Poseida Therapeutics.
Poseida Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.